Please login to the form below

Not currently logged in
Email:
Password:

AZ and Sutter Health enter cardiometabolic collaboration

Three-year partnership will design and pilot new treatments

AstraZeneca AZ headquarters London UK 

AstraZeneca has joined forces with not-for-profit organisation Sutter Health on a research and innovation collaboration on cardiometabolic healthcare.

The three-year partnership will work to design, prototype and pilot innovative approaches to the form of healthcare, which focuses on the treatment and management of diseases such as diabetes, hypertension and high cholesterol in addition to more common complications such as heart attack, blindness or death.

Greg Keenan, VP medical affairs and US medical officer at AZ, commented: “Diabetes, high blood pressure and poorly controlled cholesterol can have an enormous impact on a person's quality of life and the cost of healthcare.

“We believe that Sutter Health and AZ will bring together unique expertise and experiences to improve the lives of patients. 

“Through this innovative research collaboration, we hope to improve the future of cardiometabolic care and translate solutions into programmes that health systems nationwide could implement.”

Researchers will aim to help speed up diagnosis and improve the quality of life of patients by creating technologies and treatments through a better understanding of existing gaps in cardiometabolic care.

The collaboration will focus on three key areas; utilising key data from across the Sutter Health network into a electronic system and conduct novel analytical steps to identify gaps; personalising care by designing, developing and implementing new tools to help patients and providers work together; and supporting the continuous knowledge growth of researchers.

Article by
Kirstie Pickering

11th May 2015

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...